{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T12:56:48Z","timestamp":1783601808184,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.ejphar.2011.04.026","type":"journal-article","created":{"date-parts":[[2011,4,30]],"date-time":"2011-04-30T18:45:47Z","timestamp":1304189147000},"page":"57-62","source":"Crossref","is-referenced-by-count":19,"title":["Pemirolast reduces cisplatin-induced kaolin intake in rats"],"prefix":"10.1016","volume":"661","author":[{"given":"Yoko","family":"Tatsushima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuaki","family":"Egashira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiro","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Kurobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Kawashiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryozo","family":"Oishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2011.04.026_bb0005","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1200\/JCO.2006.06.9591","article-title":"American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006","volume":"24","author":"American Society of Clinical Oncology","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2011.04.026_bb0010","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0028-3908(93)90189-A","article-title":"Resinferatoxin, an ultrapotent capsaicin analogue, has anti-emetic properties in the ferret","volume":"32","author":"Andrews","year":"1993","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2011.04.026_bb0015","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/sj.bjp.0703428","article-title":"The emetic and anti-emetic effects of the capsaicin analogue resiniferatoxin in Suncus murinus, the house musk shrew","volume":"130","author":"Andrews","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.04.026_bb0020","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s11095-006-0068-1","article-title":"Characteristics of substance P transport across the blood\u2013brain barrier","volume":"23","author":"Chappa","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejphar.2011.04.026_bb0025","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0959-8049(00)00416-0","article-title":"Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis","volume":"37","author":"Cocquyt","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ejphar.2011.04.026_bb0030","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.brainres.2008.03.077","article-title":"Utilization of the least shrew as a rapid and selective screening model for the antiemetic potential and brain penetration of substance P and NK1 receptor antagonists","volume":"1214","author":"Darmani","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2011.04.026_bb0035","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.brainres.2008.10.063","article-title":"A re-evaluation of the neurotransmitter basis of chemotherapy-induced immediate and delayed vomiting: evidence from the least shrew","volume":"1248","author":"Darmani","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2011.04.026_bb0040","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.brainres.2009.11.005","article-title":"Differential temporal changes in brain and gut substance P mRNA expression throughout the time-course of cisplatin-induced vomiting in the least shrew (Cryptotis parva)","volume":"1310","author":"Dey","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2011.04.026_bb0045","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0196-9781(01)00592-7","article-title":"Investigation of substance P transport across the blood\u2013brain barrier","volume":"23","author":"Freed","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2011.04.026_bb0050","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000235536","article-title":"Effect of a novel antiallergic drug, pemirolast, on activation of rat peritoneal mast cells: inhibition of exocytotic response and membrane phospholipid turnover","volume":"96","author":"Fujimiya","year":"1991","journal-title":"Int. Arch. Allergy Appl. Immunol."},{"key":"10.1016\/j.ejphar.2011.04.026_bb0055","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0091-3057(01)00604-9","article-title":"Pharmacological characterization of cyclosporine A-induced kaolin intake in rats","volume":"70","author":"Fujisaki","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2011.04.026_bb0060","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0014-2999(96)00216-6","article-title":"Broad spectrum antiemetic effects of CP-122,721, a tachykinin NK1 receptor antagonist, in ferrets","volume":"305","author":"Gonsalves","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.04.026_bb0070","first-page":"14","article-title":"Single dose ondansetron for the prevention of cisplatin-induced emesis: efficacy results","volume":"19","author":"Hainsworth","year":"1992","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.ejphar.2011.04.026_bb0075","first-page":"138","article-title":"Concordance between substance P levels and antiemetic guidelines","volume":"7","author":"Higa","year":"2009","journal-title":"J. Support. Oncol."},{"key":"10.1016\/j.ejphar.2011.04.026_bb0080","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1164\/rccm.200307-901OC","article-title":"Role of sensory nerve peptides rather than mast cell histamine in paclitaxel hypersensitivity","volume":"169","author":"Itoh","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2011.04.026_bb0085","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.neuropharm.2003.11.018","article-title":"Pemirolast potently attenuates paclitaxel hypersensitivity reactions through inhibition of the release of sensory neuropeptides in rats","volume":"46","author":"Itoh","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2011.04.026_bb0090","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejphar.2006.10.043","article-title":"Differential effects of dexamethasone, ondansetron and a tachykinin NK1 receptor antagonist (GR205171) on cisplatin-induced changes in behaviour, food intake, pica and gastric function in rats","volume":"555","author":"Malik","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.04.026_bb0095","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000227637","article-title":"The severity and pattern of emesis following different cytotoxic agents","volume":"53","author":"Martin","year":"1996","journal-title":"Oncology"},{"key":"10.1016\/j.ejphar.2011.04.026_bb0100","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/286722a0","article-title":"A binding site on mast cells and basophils for the anti-allergic drug cromolyn","volume":"286","author":"Mazurek","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2011.04.026_bb0105","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0014-2999(98)00784-5","article-title":"Antiemetic effects of sendide, a peptide tachykinin NK1 receptor antagonist, in the ferret","volume":"363","author":"Minami","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.04.026_bb0110","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0014-2999(01)01297-3","article-title":"Effects of CP-99, 994, a tachykinin NK(1) receptor antagonist, on abdominal afferent vagal activity in ferrets: evidence for involvement of NK(1) and 5-HT(3) receptors","volume":"428","author":"Minami","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.04.026_bb0115","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1248\/bpb.28.473","article-title":"Increasing effect by simultaneous use of levocabastine and pemirolast on experimental allergic conjunctivitis in rats","volume":"28","author":"Minami","year":"2005","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejphar.2011.04.026_bb0120","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00005344-199708000-00002","article-title":"Effects of pemirolast and tranilast on intimal thickening after arterial injury in the rat","volume":"30","author":"Miyazawa","year":"1997","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.04.026_bb0125","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1586\/14737140.4.5.715","article-title":"Aprepitant: a neurokinin-1 receptor antagonist for the treatment of chemotherapy-induced nausea and vomiting","volume":"4","author":"Navari","year":"2004","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.ejphar.2011.04.026_bb0130","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2165\/00003495-200969050-00002","article-title":"Pharmacological management of chemotherapy-induced nausea and vomiting: focus on recent developments","volume":"69","author":"Navari","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2011.04.026_bb0135","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF00583789","article-title":"Dihydropyridine inhibition of neuronal calcium current and substance P release","volume":"409","author":"Rane","year":"1987","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.ejphar.2011.04.026_bb0140","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1476-5381.1996.tb15388.x","article-title":"An interaction of ondansetron and dexamethasone antagonizing cisplatin-induced acute and delayed emesis in the ferret","volume":"118","author":"Rudd","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.04.026_bb0145","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/j.1476-5381.1996.tb15761.x","article-title":"The action of the NK1 tachykinin receptor antagonist, CP 99,994, in antagonizing the acute and delayed emesis induced by cisplatin in the ferret","volume":"119","author":"Rudd","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.04.026_bb0150","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0014-2999(02)02472-X","article-title":"Differential action of ondansetron and dexamethasone to modify cisplatin-induced acute and delayed kaolin consumption (\u201cpica\u201d) in rats","volume":"454","author":"Rudd","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.04.026_bb0155","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0014-2999(97)85415-5","article-title":"In vitro and in vivo predictors of the anti-emetic activity of tachykinin NK1 receptor antagonists","volume":"326","author":"Rupniak","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.04.026_bb0160","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1254\/jjp.86.359","article-title":"Effects of HSP-117, a novel tachykinin NK1-receptor antagonist, on cisplatin-induced pica as a new evaluation of delayed emesis in rats","volume":"86","author":"Saeki","year":"2001","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.04.026_bb0165","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1254\/fpj.127.461","article-title":"Easy method for emesis using rats","volume":"127","author":"Saito","year":"2006","journal-title":"Nippon Yakurigaku Zasshi"},{"key":"10.1016\/j.ejphar.2011.04.026_bb0170","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1254\/jphs.91.87","article-title":"Roles of substance P and NK(1) receptor in the brainstem in the development of emesis","volume":"91","author":"Saito","year":"2003","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2011.04.026_bb0175","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.peptides.2004.04.004","article-title":"Role of substance P in hypersensitivity reactions induced by paclitaxel, an anticancer agent","volume":"25","author":"Sendo","year":"2004","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2011.04.026_bb0180","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0014-2999(96)00950-8","article-title":"The tachykinin NK1 receptor antagonist PD 154075 blocks cisplatin-induced delayed emesis in the ferret","volume":"321","author":"Singh","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.04.026_bb0185","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0091-3057(93)90126-E","article-title":"Pica in rats is analogous to emesis: an animal model in emesis research","volume":"45","author":"Takeda","year":"1993","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2011.04.026_bb0190","first-page":"647","article-title":"Neuropharmacological mechanisms of emesis. II. Effects of antiemetic drugs on cisplatin-induced pica in rats","volume":"17","author":"Takeda","year":"1995","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.04.026_bb0195","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0028-3908(96)00020-2","article-title":"Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets","volume":"35","author":"Tattersall","year":"1996","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2011.04.026_bb0200","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0028-3908(99)00172-0","article-title":"The novel NK1 receptor antagonist MK-0869 (L-754,030) and its water soluble phosphoryl prodrug, L-758,298, inhibit acute and delayed cisplatin-induced emesis in ferrets","volume":"39","author":"Tattersall","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2011.04.026_bb0205","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/0959-8049(95)00192-L","article-title":"Comparison of granisetron alone and granisetron plus hydroxyzine hydrochloride for prophylactic treatment of emesis induced by cisplatin chemotherapy","volume":"31A","author":"Tsukuda","year":"1995","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ejphar.2011.04.026_bb0210","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000227054","article-title":"Mechanism of the anti-emetic activity of 5-HT3 receptor antagonists","volume":"49","author":"Tyers","year":"1992","journal-title":"Oncology"},{"key":"10.1016\/j.ejphar.2011.04.026_bb0215","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1476-5381.1995.tb16324.x","article-title":"The anti-emetic effects of CP-99,994 in the ferret and the dog: role of the NK1 receptor","volume":"115","author":"Watson","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.04.026_bb0220","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0306-4522(95)00353-3","article-title":"Mechanism of prostaglandin E2-induced substance P release from cultured sensory neurons","volume":"70","author":"White","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2011.04.026_bb0225","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1002\/ijc.21680","article-title":"Prophylactic effect of pemirolast, an antiallergic agent, against hypersensitivity reactions to paclitaxel in patients with ovarian cancer","volume":"118","author":"Yahata","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejphar.2011.04.026_bb0230","first-page":"903","article-title":"Substance P and anticancer drug-induced emesis","volume":"34","author":"Yamada","year":"2007","journal-title":"Gan To Kagaku Ryoho"},{"key":"10.1016\/j.ejphar.2011.04.026_bb0235","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejphar.2006.09.058","article-title":"The anti-cancer drug-induced pica in rats is related to their clinical emetogenic potential","volume":"554","author":"Yamamoto","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.04.026_bb0240","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1254\/jjp.48.103","article-title":"Immunopharmacological studies on TBX, a new antiallergic drug (2). Inhibitory effects on histamine release from peritoneal mast cells and lung fragments of rats","volume":"48","author":"Yanagihara","year":"1988","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.04.026_bb0245","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S1081-1206(10)63063-3","article-title":"Comparative effects of topical ocular anti-allergy drugs on human conjunctival mast cells","volume":"79","author":"Yanni","year":"1997","journal-title":"Ann. Allergy Asthma Immunol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991100416X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991100416X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T04:54:07Z","timestamp":1543812847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429991100416X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":48,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S001429991100416X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2011.04.026","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}